{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:30:42Z","timestamp":1784863842688,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.humpath.2011.08.008","type":"journal-article","created":{"date-parts":[[2011,12,11]],"date-time":"2011-12-11T18:41:17Z","timestamp":1323628877000},"page":"153-164","source":"Crossref","is-referenced-by-count":22,"title":["Erythroid proliferations in myeloid neoplasms"],"prefix":"10.1016","volume":"43","author":[{"given":"Sa A.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Hasserjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2011.08.008_bb0005","first-page":"386","article-title":"Richerche di ematologia. I. Un caso di eritroleucemia. Megacariociti in circolo e loro funzione piastrinopoietico","volume":"13","author":"Di Guglielmo","year":"1917","journal-title":"Folia Medica"},{"key":"10.1016\/j.humpath.2011.08.008_bb0010","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.08.008_bb0015","series-title":"Le Malatte Eritremiche ed Eritroleucemiche II Pensiero Scientifico","author":"Di Guglielmo","year":"1962"},{"key":"10.1016\/j.humpath.2011.08.008_bb0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2141.1975.tb00909.x","article-title":"The relationship between morphology and other features of acute myeloid leukaemia and their prognostic significance. Report on the Medical Research Council's Working Party on Leukaemia in Adults","volume":"31","author":"Galton","year":"1975","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0025","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0030","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","article-title":"Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group","volume":"103","author":"Bennett","year":"1985","journal-title":"Ann Inter Med"},{"key":"10.1016\/j.humpath.2011.08.008_bb0035","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting\u2014Airlie House, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/jcp.54.3.205","article-title":"Acute erythremic myelosis (true erythroleukaemia): a variant of AML FAB-M6","volume":"54","author":"Hasserjian","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/1096-8652(200009)65:1<5::AID-AJH2>3.0.CO;2-U","article-title":"Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases","volume":"65","author":"Kowal-Vern","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0050","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2141.1995.tb05208.x","article-title":"Minimally differentiated erythroleukaemia (AML M6 \u2018variant\u2019): a rare subset of AML distinct from AML M6. Groupe Francais d'Hematologie Cellulaire","volume":"90","author":"Garand","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ajcp\/98.1.34","article-title":"The prognostic significance of proerythroblasts in acute erythroleukemia","volume":"98","author":"Kowal-Vern","year":"1992","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0060","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0272-2712(18)30080-5","article-title":"The acute erythroleukemias","volume":"20","author":"Mazzella","year":"2000","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.humpath.2011.08.008_bb0070","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/ajcp\/110.5.590","article-title":"Acute erythroleukemia: evaluation of 48 cases with reference to classification, cell proliferation, cytogenetics, and prognosis","volume":"110","author":"Mazzella","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0075","first-page":"148","article-title":"Acute erythroid neoplastic proliferations. A biological study based on 62 patients","volume":"87","author":"Domingo-Claros","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2011.08.008_bb0080","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/ajh.20563","article-title":"Prognostic significance of pronormoblasts in erythrocyte predominant myelodysplastic patients","volume":"81","author":"Mazzella","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0085","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.08.008_bb0090","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/sj.leu.2404233","article-title":"A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare \u2018poor prognosis\u2019 myeloid malignancies","volume":"20","author":"Slovak","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2011.08.008_bb0095","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/modpathol.3880070","article-title":"Effects of multidrug resistance gene expression in acute erythroleukemia","volume":"13","author":"Mazzella","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0100","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2011.043687","article-title":"Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all demonstrating more than 50% of bone marrow erythropoietic cells","author":"Bacher","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2011.08.008_bb0105","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1182\/blood-2009-08-240457","article-title":"Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1)","volume":"115","author":"Falini","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.08.008_bb0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1309\/NQ3PMV4U8YV39JWJ","article-title":"Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant","volume":"127","author":"Singh","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0115","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1986.4.12.1748","article-title":"Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features","volume":"4","author":"Kantarjian","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0120","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/blood-2008-10-182782","article-title":"Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system","volume":"113","author":"Weinberg","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.08.008_bb0125","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood-2009-09-243964","article-title":"Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification","volume":"115","author":"Hasserjian","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.08.008_bb0130","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/modpathol.2008.142","article-title":"Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification","volume":"21","author":"Wang","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood-2002-11-3343","article-title":"Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series","volume":"102","author":"Smith","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.08.008_bb0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cancergencyto.2005.05.006","article-title":"Cytogenetic study of 75 erythroleukemias","volume":"163","author":"Lessard","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.humpath.2011.08.008_bb0145","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s11912-002-0032-0","article-title":"Cytogenetics in acute myeloid leukemia","volume":"4","author":"Schoch","year":"2002","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.humpath.2011.08.008_bb0150","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1038\/leu.2009.181","article-title":"Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution","volume":"23","author":"Santos","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2011.08.008_bb0155","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/modpathol.2010.194","article-title":"Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification","volume":"24","author":"Liu","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0160","first-page":"124","article-title":"Acute myeloid leukaemia with myelodysplasia-related changes","author":"Arber","year":"2008"},{"key":"10.1016\/j.humpath.2011.08.008_bb0165","first-page":"3671","article-title":"Report of an international working group to standardize response criteria for myelodysplastic syndromes","volume":"96","author":"Cheson","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.08.008_bb0170","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1182\/blood-2002-05-1440","article-title":"Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm","volume":"100","author":"Frohling","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.08.008_bb0175","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/sj.leu.2404316","article-title":"Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features","volume":"20","author":"Wang","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2011.08.008_bb0180","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.humpath.2005.07.020","article-title":"Myelodysplastic\/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case","volume":"36","author":"Heiss","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0185","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/sj.leu.2402549","article-title":"Erythroleukemia: a need for a new definition","volume":"16","author":"Park","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2011.08.008_bb0190","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/sj.leu.2403316","article-title":"Erythroleukaemia and RAEB-t: a same disease?","volume":"18","author":"Park","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2011.08.008_bb0195","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1182\/blood.V80.11.2873.2873","article-title":"Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia","volume":"80","author":"Olopade","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.08.008_bb0200","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.08.008_bb0205","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s12185-008-0183-3","article-title":"Clinicopathological characteristics of erythroblast-rich RAEB and AML M6a in children","volume":"88","author":"Honda","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0210","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical effect of point mutations in myelodysplastic syndromes","volume":"364","author":"Bejar","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2011.08.008_bb0215","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.08.008_bb0220","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1200\/JCO.2008.16.0259","article-title":"Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype","volume":"26","author":"Breems","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00000421-199802000-00010","article-title":"The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease","volume":"21","author":"Goldberg","year":"1998","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/leu.2009.157","article-title":"Myelodysplastic syndromes: lost between two states?","volume":"24","author":"Acquaviva","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2011.08.008_bb0235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cbi.2009.10.009","article-title":"The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms","volume":"184","author":"Vardiman","year":"2010","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.humpath.2011.08.008_bb0240","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/sj.leu.2404564","article-title":"A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification","volume":"21","author":"Verburgh","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2011.08.008_bb0245","first-page":"189","article-title":"Bone marrow findings before and after treatment with recombinant human erythropoietin in chronic hemodialyzed patients","volume":"43","author":"Ahn","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0250","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000169086","article-title":"How erythropoietin affects bone marrow of uremic patients","volume":"17","author":"Sikole","year":"1997","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0255","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0145-2126(96)00110-5","article-title":"Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin","volume":"21","author":"Hellstrom-Lindberg","year":"1997","journal-title":"Leuk Res"},{"key":"10.1016\/j.humpath.2011.08.008_bb0260","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1365-2141.1997.4013211.x","article-title":"Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model","volume":"99","author":"Hellstrom-Lindberg","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0265","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000203977","article-title":"Alcoholic dyshaematopoiesis: morphological features of alcohol-induced bone marrow damage in biopsy sections compared with aspiration smears","volume":"94","author":"Budde","year":"1995","journal-title":"Acta Haematol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0270","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1742-1241.1990.tb10169.x","article-title":"Anti-tuberculous drugs and sideroblastic anaemia","volume":"44","author":"Sharp","year":"1990","journal-title":"Br J Clin Pract"},{"key":"10.1016\/j.humpath.2011.08.008_bb0275","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/jama.1990.03450110087033","article-title":"Excessive zinc ingestion. A reversible cause of sideroblastic anemia and bone marrow depression","volume":"264","author":"Broun","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.humpath.2011.08.008_bb0280","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1182\/blood-2002-01-0256","article-title":"Copper deficiency masquerading as myelodysplastic syndrome","volume":"100","author":"Gregg","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.08.008_bb0285","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00000441-200610000-00008","article-title":"Pregnancy-induced pancytopenia with cellular bone marrow: distinctive hematologic features","volume":"332","author":"Natelson","year":"2006","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.humpath.2011.08.008_bb0290","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1479-828X.2009.00952.x","article-title":"Acquired sideroblastic anaemia following progesterone treatment in pregnancy","volume":"49","author":"Bencaiova","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0295","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00043426-199707000-00002","article-title":"Sideroblastic anemia: a mitochondrial disorder","volume":"19","author":"Bridges","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.humpath.2011.08.008_bb0300","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/sj.leu.2401613","article-title":"Sideroblastic anemia following treatment of chronic myeloid leukemia with busulfan","volume":"14","author":"Magalhaes","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2011.08.008_bb0305","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.leukres.2011.04.021","article-title":"Transient\/reversible ring sideroblasts in bone marrow of patients post cytotoxic therapies for primary malignancies","volume":"35","author":"Ok","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.humpath.2011.08.008_bb0310","first-page":"224","article-title":"Karyotype and molecular cytogenetic studies in polycythemia vera","volume":"4","author":"Andrieux","year":"2005","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.humpath.2011.08.008_bb0315","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0145-2126(00)00088-6","article-title":"Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients","volume":"24","author":"Germing","year":"2000","journal-title":"Leuk Res"},{"key":"10.1016\/j.humpath.2011.08.008_bb0320","first-page":"1596","article-title":"Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes","volume":"91","author":"Germing","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2011.08.008_bb0325","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1182\/blood-2010-04-279794","volume":"116","author":"Miesner","year":"2010","journal-title":"Blood"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817711003443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817711003443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T18:02:57Z","timestamp":1686506577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817711003443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0046817711003443"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2011.08.008","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}